HOOKIPA Pharma Inc. (HOOK)
OTCMKTS
· Delayed Price · Currency is USD
1.100
0.00 (0.00%)
Apr 27, 2026, 3:28 PM EST
HOOKIPA Pharma Employees
As of December 31, 2024, HOOKIPA Pharma had 87 total employees, including 82 full-time and 5 part-time employees. The number of employees decreased by 92 or -51.40% compared to the previous year.
Employees
87
Change (1Y)
-92
Growth (1Y)
-51.40%
Revenue / Employee
$110,012
Profits / Employee
-$862,506
Market Cap
14.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Inhibitor Therapeutics | 8 |
| Zeo ScientifiX | 20 |
| Oncotelic Therapeutics | 26 |
| Anebulo Pharmaceuticals | 3 |
| Provectus Biopharmaceuticals | 6 |
| Brainstorm Cell Therapeutics | 20 |
HOOKIPA Pharma News
- 3 months ago - HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics - GlobeNewsWire
- 6 months ago - HOOKIPA Pharma Announces Completion of Sale of HBV and HIV Assets to Gilead - GlobeNewsWire
- 10 months ago - HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock - GlobeNewsWire
- 1 year ago - HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”) - GlobeNewsWire
- 1 year ago - Poolbeg Pharma plc (“Poolbeg”) and HOOKIPA Pharma Inc. (“HOOKIPA”) Update on Potential Combination of Poolbeg and HOOKIPA - GlobeNewsWire
- 1 year ago - HOOKIPA Pharma Inc - FORM 8 (OPD) - GlobeNewsWire
- 1 year ago - HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements - GlobeNewsWire
- 1 year ago - HOOKIPA Pharma Inc. (“HOOKIPA”) Rule 2.9 Announcement – Amendment - GlobeNewsWire